Startups
Cellworks is a world leader in Precision Medicine. We help physicians and payers navigate to the most efficacious, cost-effective treatments for patients in a transparent and timely manner. Cellworks’ key therapeutic areas are Oncology, Immunology, Dermatology and Infectious Diseases. Cellworks’ unique bio-simulation platform is a unified representation of biological knowledge, curated from heterogeneous datasets, applied to finding cure. Since 2005, backed by Artiman Ventures and Sequoia Capital, Cellworks has the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers, and internet software technologists working towards a common goal – attacking serious diseases to improve the lives of patients.
Overview
Location
United States, California, South San Francisco
Employees
51-200
Phone
+1 650-418-3804
Founded date
2005
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 22, 2026 | Cellworks Presents Novel Mechanistic Approach to Predicting Drug–Drug Interaction Risk in Oncology at AACR 2026 | Study suggests biologically grounded predictions could reduce safety-related failures in combination therapies in drug development and clinical care settings SAN DIEGO, CA, UNITED STATES, April 22, 2026 /EINPresswire.com/ -- Cellworks Group... |
| Apr 22, 2026 | Cellworks Study Supports Liquid Biopsy for Predicting Chemo-Immunotherapy Benefit in Advanced NSCLC | New findings show potential for liquid biopsy to expand access to personalized treatment prediction in advanced NSCLC SAN DIEGO, CA, UNITED STATES, April 22, 2026 /EINPresswire.com/ -- Cellworks Group Inc., the leader in Personalized Therap... |
Reviews 0
FAQ about CellworksLife
When was CellworksLife founded?
CellworksLife was founded in 2005.
What has the press written about CellworksLife?
Parsers VC has collected 3 articles mentioning CellworksLife, among them “Cellworks Presents Novel Mechanistic Approach to Predicting Drug–Drug Interaction Risk in Oncology at AACR 2026” (Apr 22, 2026) and “Cellworks Study Supports Liquid Biopsy for Predicting Chemo-Immunotherapy Benefit in Advanced NSCLC” (Apr 22, 2026).
Is CellworksLife still active?
Yes, CellworksLife is active; its latest activity on Parsers VC dates from Apr 22, 2026.